MIRA Pharmaceuticals, Inc.
MIRA
$0.78
$0.000.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.21M | -1.15M | -5.98M | -1.14M | -1.54M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 109.40K | 199.20K | 4.77M | 214.80K | 489.60K |
| Change in Net Operating Assets | -106.50K | -250.30K | 79.10K | -174.10K | 248.50K |
| Cash from Operations | -1.21M | -1.20M | -1.14M | -1.10M | -799.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 572.90K | -348.70K | 348.70K |
| Total Debt Repaid | 0.00 | -330.60K | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 4.43M | 3.47M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -3.40K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -158.40K | -112.60K | -21.50K |
| Cash from Financing | 0.00 | -330.60K | 4.84M | 3.01M | 323.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.21M | -1.53M | 3.71M | 1.91M | -475.80K |